Clinical Trials

Phase 3 Not yet recruiting

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

320 enrolled

Pancreatic Neoplasms

NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Phase 3 Terminated

10 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT04415853 2025-05-18

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Phase 3 Recruiting

416 enrolled

Esophageal Neoplasms

NCT01515748 2023-12-13

PRODIGY

530 enrolled 11 charts

Phase 3 Not yet recruiting

Stomach Neoplasms

NCT05914610 2023-08-25

Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer

100 enrolled

Stomach Neoplasms

NCT00207831 2020-03-25

UFT RT Phase 3

Phase 3 Terminated

219 enrolled

Rectal Neoplasms

NCT04135781 2020-03-23

Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

616 enrolled

Stomach Neoplasms

NCT03941561 2019-05-31

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

Phase 3 Recruiting

1,006 enrolled

Stomach Neoplasms

NCT03475615 2018-03-23

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

215 enrolled

Stomach Neoplasms

NCT00392899 2016-09-28

Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery

2,025 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00660894 2016-08-03

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

1,535 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00336947 2013-05-15

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

500 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00385970 2012-10-26

A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

380 enrolled

Colorectal Neoplasms

NCT01198392 2011-07-25

Trial of S-1 Plus Cisplatin in Gastric Cancer

270 enrolled

Stomach Neoplasms

NCT00152178 2011-07-07

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

680 enrolled

Breast

Breast Neoplasms

NCT00152191 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

1,300 enrolled

Breast

Breast Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

900 enrolled

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

500 enrolled

Stomach Neoplasms

NCT00209742 2010-05-26

Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

340 enrolled

Colorectal Neoplasms

NCT00378716 2010-01-11

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

1,608 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00497107 2008-07-31

ICOG

300 enrolled

Colorectal Neoplasms

NCT00139971 2006-01-06

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer